首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1800137

全球基因檢測市場：2025年至2030年預測

Global Genetic Testing Market - Forecasts fom 2025 to 2030

出版日期: 2025年08月08日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

基因檢測市場規模預計將從 2025 年的 149.04 億美元成長至 2030 年的 248.89 億美元，複合年成長率為 10.80%。

由於人口老化、遺傳病患病率上升以及人們對早期疾病檢測意識的不斷增強等因素，基因檢測市場正經歷強勁成長。技術進步和預防性醫療保健應用的不斷擴展進一步推動了市場的發展。研發投入正在推動技術創新，並將基因檢測定位為醫療診斷的關鍵工具。然而，高成本可能會抑製成長。本摘要專為行業專業人士量身定做，重點介紹了截至2025年的關鍵促進因素、區域趨勢和競爭考察。

市場成長動力

遺傳疾病盛行率的上升以及對早期檢測和個人化醫療日益成長的重視，推動了基因檢測市場的發展。全球人口老化加劇了對遺傳疾病檢測的需求。包括次世代定序和檢測設備改進在內的技術進步，正在提高檢測的準確性和可及性，促進其在醫療保健和科研領域的應用。研發投入的增加正在加速技術創新，新的檢測方法也正在擴大其在疾病預防和管理的應用。然而，高昂的檢測成本、不一致的報銷政策以及熟練專業人員的短缺構成了挑戰，尤其是在法律規範仍在發展的新興市場。

地理視角

北美在基因檢測市場佔據主導地位，這得益於先進的技術基礎設施、高發生率的遺傳疾病以及強勁的研發投入。該地區完善的醫療保健體系和基因檢測在診斷領域的廣泛應用，確保了其市場領先地位。然而，預計亞太地區將經歷最快的成長，這得益於患者人數的增加、購買力的提升以及中國和印度等國家政府對醫療創新的資助。儘管有這樣的潛力，但高昂的成本和監管的不確定性可能會限制亞太地區和其他新興經濟體的成長。

調查方法

我們的市場分析採用嚴謹的方法，將產業報告中的二手資料與相關人員的一手資料結合並檢驗。市場規模和預測採用自上而下和自下而上的方法計算，以確保準確性。報告按應用、技術和地區細分市場，以提供全面的趨勢和機會視角。產業價值鏈分析和波特五力模型進一步揭示了市場動態、監管影響和競爭壓力。

競爭考察

基因檢測市場的主要企業包括羅氏公司 (F. Hoffmann-La Roche Ltd.)、23&Me, Inc.、Precipio, Inc.、AutoGenomics、雅培實驗室 (Abbott Laboratories) 和 Luminex Corporation。這些公司透過持續研發、產品創新和策略聯盟來推動市場成長。他們專注於開發先進的檢測平台，以提高診斷準確性並推動市場發展。由於需要大量的研發成本和專業知識，進入門檻較高，從而塑造了競爭格局，增強了現有企業的市場影響力。

受人口老化、遺傳病患疾病上升以及技術進步的推動，基因檢測市場可望迎來顯著成長。北美市場目前處於領先地位，而亞太地區則因醫療保健投資的增加而逐漸成為高成長地區。儘管高成本和監管缺口等挑戰依然存在，但持續的研發和技術創新可望支撐市場持續擴張。領先的公司不斷透過先進的解決方案鞏固其市場地位，將基因檢測定位為現代醫療保健的基石。

本報告的主要優點

深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
競爭格局：了解主要企業採用的策略策略，並了解正確策略的市場滲透潛力。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力進行策略決策並在動態環境中開闢新的業務流和收益。
適合廣泛的使用者：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具有成本效益的。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

2020 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭定位、策略和市場佔有率分析
收益成長和預測細分市場和區域分析（包括國家）
公司概況（尤其是趨勢）、財務資訊和關鍵發展

The global genetic testing market is experiencing robust growth, driven by an aging population, increasing prevalence of genetic and hereditary diseases, and growing awareness of early disease detection. Technological advancements and expanding applications in preventive healthcare further propel the market. Investments in research and development (R&D) are fostering innovation, positioning genetic testing as a critical tool in medical diagnostics. However, challenges such as high costs, unclear reimbursement structures, lack of skilled personnel, and regulatory gaps may restrain growth. This summary, tailored for industry experts, highlights key drivers, geographical trends, and competitive insights as of 2025.

Market Growth Drivers

The genetic testing market is fueled by the rising incidence of genetic disorders and the growing emphasis on early detection and personalized medicine. An aging global population increases demand for tests to identify hereditary conditions. Technological advancements, including next-generation sequencing and improved testing equipment, enhance accuracy and accessibility, driving adoption across medical and research sectors. Increased R&D investments are accelerating innovation, with new testing methodologies expanding applications in disease prevention and management. However, high testing costs, inconsistent reimbursement policies, and a shortage of skilled professionals pose challenges, particularly in emerging markets where regulatory frameworks are still evolving.

Geographical Outlook

North America dominates the genetic testing market, supported by advanced technological infrastructure, a high prevalence of genetic diseases, and robust R&D investments. The region's well-established healthcare systems and widespread adoption of genetic testing for diagnostics ensure its market leadership. The Asia-Pacific (APAC) region, however, is projected to experience the fastest growth, driven by a rising patient pool, increasing purchasing power, and government funding for healthcare innovation in countries like China and India. Despite this potential, high costs and regulatory uncertainties may limit growth in APAC and other emerging economies.

Research Methodology

The market analysis employs a rigorous methodology, combining secondary data from industry reports and primary inputs from stakeholders for validation. Market size and forecasts are calculated using both top-down and bottom-up approaches, ensuring accuracy. The report segments the market by application, technology, and geography, providing a comprehensive view of trends and opportunities. Industry value chain analysis and Porter's Five Forces model further elucidate market dynamics, regulatory influences, and competitive pressures.

Competitive Insights

Key players in the genetic testing market include F. Hoffmann-La Roche Ltd, 23&Me, Inc., Precipio, Inc., AutoGenomics, Abbott Laboratories, and Luminex Corporation. These companies drive market growth through continuous R&D, product innovation, and strategic partnerships. Their focus on developing advanced testing platforms enhances diagnostic precision and expands market reach. The competitive landscape is shaped by high entry barriers due to significant R&D costs and the need for specialized expertise, consolidating market dominance among established players.

The genetic testing market is poised for significant growth, driven by an aging population, rising genetic disease prevalence, and technological advancements. North America leads, while APAC emerges as a high-growth region due to increasing healthcare investments. Challenges like high costs and regulatory gaps persist, but ongoing R&D and innovation are expected to sustain market expansion. Major players continue to strengthen their positions through advanced solutions, positioning genetic testing as a cornerstone of modern healthcare.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2020 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

The genetic testing market has been segmented by product type, diseases, technology, and geography:

By Type

Prenatal Testing
New Born Screening
Diagnostic Testing
Carrier Testing
Predictive & Pre-symptomatic Testing

By Diseases

Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne's Muscular Dystrophy
Alzheimer's Diseases
Thalassemia
Huntington's Disease
Others

By Technology

Cyto-genetics Testing
Biochemical Testing
Molecular Testing
Others

By Geography

North America
United States
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
Japan
China
India
Australia
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL GENETIC TESTING MARKET BY TYPE

5.1. Introduction
5.2. Prenatal Testing
5.3. New Born Screening
5.4. Diagnostic Testing
5.5. Carrier Testing
5.6. Predictive & Pre-symptomatic Testing

6. GLOBAL GENETIC TESTING MARKET BY DISEASE

6.1. Introduction
6.2. Cancer
6.3. Cystic Fibrosis
6.4. Sickle Cell Anemia
6.5. Duchenne's Muscular Dystrophy
6.6. Alzheimer's Disease
6.7. Thalassemia
6.8. Huntington's Disease
6.9. Others

7. GLOBAL GENETIC TESTING MARKET BY TECHNOLOGY

7.1. Introduction
7.2. Cyto-genetics Testing
7.3. Biochemical Testing
7.4. Molecular Testing
7.5. Others

8. GLOBAL GENETIC TESTING MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Italy
- 8.4.5. Others
8.5. Middle East & Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. Australia
- 8.6.5. Others